TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 8 Sept 2025, 14:23 BST

Official UK procurement notice

Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults)

Official notice

Authority: NHS England (Central government)

7 lotsServicesOpen procedure
Sectors: Health & Social Care (85) Delivery: UKNorth East (UKC)North West (UKD)
+7 moreYorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Published estimate£142,512,000total for 7 lots
Submissions closed 13 Oct 2025awarded 16 Dec 2025
Awarded to University College London Hospitals NHS Foundation Trust +9 more10 awards

What is being bought7 lots · detail below

Published requirement description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults). <br/><br/>Lifileucel is a first in class autologous tumour infiltrating lymphocyte (TIL) cell therapy. This infusion is followed by a short course of interleukin-2 (IL-2). IL-2 is a potent drug and has the potential to cause significant side effects. As such, it is recommended that patients receive treatment at a trust with immediate access to an Intensive Therapy<br/>Unit (ITU).<br/><br/>Lifileucel is being assessed via NICE’s technology appraisal programme for previously treated unresectable or metastatic melanoma in adults, with an expected final guidance publication date in 2026 in line with NICE guidance: www.nice.org.uk/guidance/indevelopme… ↗<br/><br/>The treatment is complex to administer, requiring surgical expertise for tumour<br/>resection, melanoma expertise for patient selection and management post-treatment and cell therapy expertise to administer the cell therapy and manage the side effects and associated care of both Lifileucel and IL-2 administration.<br/><br/>The key objective of the Procurement was to commission Tumour Infiltrating Lymphocyte (TIL)Therapy Hubs for adult patients across the following seven (7) geographical regions to serve the population of England:<br/>Lot 1: London<br/>Lot 2: East of England<br/>Lot 3: South East<br/>Lot 4: South West<br/>Lot 5: Midlands<br/>Lot 6: North East and Yorkshire<br/>Lot 7: North West<br/><br/>This process was designed to enable any provider meeting the required standards to be awarded a contract, with no restriction on the number of sites commissioned.<br/><br/>As a result of this procurement exercise the commissioner intends to award 12 separate contracts across the 7 Lots.<br/><br/>The service is due to commence on 1st May 2025, subject to NICE guidance, for a period of 5 years with the Commissioners having the option to extend for up to an additional 4 year(s)(maximum contract duration 9 years).

CPV: Health services

Lots and requirements (7)Procurement structure

7 lots · 1 with a published value · same evaluation weights on every lot
Lot #1LondonCancelled UK, LondonPublished value£142,512,000
Delivery: UK, London
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).Variant bids: not allowed
85100000 Health services
Lot #2East of EnglandCancelled East of EnglandLot estimate not published
Delivery: East of England
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services
Lot #3South EastCancelled South EastLot estimate not published
Delivery: South East
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services
Lot #4South WestCancelled South WestLot estimate not published
Delivery: South West
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services
Lot #5MidlandsCancelled East Midlands, West MidlandsLot estimate not published
Delivery: East Midlands, West Midlands
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services
Lot #6North East & YorkshireCancelled North East, Yorkshire & HumberLot estimate not published
Delivery: North East, Yorkshire & Humber
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services
Lot #7North WestCancelled North WestLot estimate not published
Delivery: North West
Extensions: Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
85100000 Health services

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 7 lots
Quality: 69%Social value: 10%Environmental: 21%
Published sub-criteria (5)
  • Quality & innovation: 50%
  • Value: 2%
  • Improving Access, Reducing Health Inequalities and Facilitating Choice: 17%
  • Social Value: 10%
  • Integration, Collaboration & Service Sustainability: 21%
Published award criteria (6)
  • Quality & innovation: 50
  • Value: 2
  • Integration, Collaboration & Service Sustainability: 21
  • Improving Access, Reducing Health Inequalities and Facilitating Choice: 17
  • Social Value: 10
  • Not Applicable: 0

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
8 Sept 2025, 14:23 BST
Last source update
16 Jan 2026, 12:42 GMT
Award evaluation window
13 Oct 2025 – …
FTS notice number
2026/S 000-003869
Classification (CPV)
Health services
Delivery area
UKNorth East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)
+2 moreSouth East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-0595dd Find a Tender

Publisher note: This is a Provider Selection Regime(PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by Wednesday 28th January 2026. Representations should be sent to jessica.gaucher-thompson@nhs.net. The award decision-makers are NHS England National Commissioning Group (NCG).<br/><br/>These contracts have not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>The Key Criteria used for the award:<br/>Quality & innovation: 50%<br/>Value: 2%<br/>Integration, Collaboration & Service Sustainability: 21%<br/>Improving Access, Reducing Health Inequalities and Facilitating Choice: 17%<br/>Social Value: 10%.<br/><br/>The rationale for selecting the provider(s) was based on them meeting all mandatory requirements and achieving the minimum quality threshold set out in the procurement documentation. This decision has been made as per NHS England governance processes, by the National Commissioning Group on 16th December 2025. No conflicts of Interest were identified amongst decision-makers.

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated

Tender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗

Submission deadline
13 Oct 2025, 12:00 BST
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bids opened
13 Oct 2025, 12:00 BST
Detailed submission instructions & authority contactsFrom official release

health-family.force.com/s/Welcome ↗

Timeline

13 Oct 2025 → 13 Oct 2026 · 4 dates
  1. Submission deadline381 days ago
    13 Oct 2025, 12:00 BST
  2. Bids opened381 days ago
    13 Oct 2025, 12:00 BST
  3. Notice published285 days ago
    16 Jan 2026, 12:42 GMT
  4. Bids must remain valid until15 days ago
    13 Oct 2026, 23:59 BST

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to complete
    16 Jan 2026, 12:42 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 12
Awarded value Not summedeach provider’s award repeats the list or panel total
Bids received 4
Contracts signed 12latest 16 Dec 2025
Awarded toValueDateStatus
Not linked to a lot10 awards
University College London Hospitals NHS Foundation Trust£11,876,000 †—Awarded
The Newcastle upon Tyne Hospitals NHS Foundation Trust£11,876,000 †—Awarded
The Christie NHS Foundation Trust£11,876,000 †—Awarded
THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST£11,876,000 †—Awarded
Guy's and St Thomas' NHS Foundation Trust£11,876,000 †—Awarded
Barts Health NHS Trust£11,876,000 †—Awarded
The Royal Marsden NHS Foundation Trust£11,876,000 †—Awarded
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST£11,876,000 †—Awarded
Oxford University Hospitals NHS FT£11,876,000 †—Awarded
University Hospitals Southampton£11,876,000 †—Awarded

2 further award records carry no date or value.

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
4bids———

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral GovernmentBody governed by public lawHealth Wellington House, 133-135 Waterloo Rd, London, South East, SE1 8UGContact name, email Published organisation website ↗

Dispute resolution & review bodies

Bidders & participating suppliers

12 commercial parties on the notice
Show 2 more suppliers

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.